First Patient Dosed in Akeso’s Phase III Trial of Cadonilimab for Resectable Gastric Cancer
Hong Kong, August 20, 2025 — Akeso, Inc. (9926.HK) has announced the enrollment and dosing of the first patient...
Micafungin
Advertisement
FDA Approves Merck Animal Health’s BRAVECTO QUANTUM – First Once-Yearly Injection Flea & Tick Protection for Dogs
July 10, 2025 – The U.S. Food and Drug Administration (FDA) has approved BRAVECTO® QUANTUM (fluralaner for extended-release injectable...
FDA Launches PreCheck Program to Strengthen U.S. Drug Manufacturing
August 7, 2025 – The U.S. Food and Drug Administration (FDA) has announced the launch of FDA PreCheck, a...
IQVIA and Veeva Forge Landmark Global Partnership, Ending Legal Disputes
Research Triangle Park, NC & Pleasanton, CA – August 20, 2025 – After years of high-profile legal battles, life...
Affordable Alternative: Glenmark Announces U.S. Launch of Micafungin for Injection USP
Mahwah, New Jersey, August 19, 2025 – Glenmark Pharmaceuticals Inc., USA is set to introduce Micafungin for Injection USP...
Advertisement
